Indivior (INDV) accounting chief adds 1,500 shares in market or private buy
Rhea-AI Filing Summary
Indivior Pharmaceuticals, Inc. (INDV) reported that Chief Accounting Officer Anderson Woodrow D purchased 1,500 shares of its Common Stock on August 27, 2026 in an open market or private transaction at a price of $35.69 per share. Following this transaction, he directly owns 27,638 shares of Indivior common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,500 shares
Net Buy
1 txn
Insider
Anderson Woodrow D
Role
Chief Accounting Officer
Bought
1,500 shs ($54K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,500 | $35.69 | $54K |
Holdings After Transaction:
Common Stock — 27,638 shares (Direct)
Key Figures
Shares purchased: 1,500 shares of Common Stock
Purchase price per share: $35.69 per share
Shares owned after transaction: 27,638 shares
3 metrics
Shares purchased
1,500 shares of Common Stock
Open market or private purchase on August 27, 2026
Purchase price per share
$35.69 per share
Price for the 1,500-share purchase on August 27, 2026
Shares owned after transaction
27,638 shares
Direct ownership by Anderson Woodrow D after the reported purchase
Key Terms
Form 4, Common Stock, Rule 10b5-1, open market or private transaction
4 terms
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Rule 10b5-1 regulatory
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open market or private transaction financial
"transaction_code_description: "Purchase in open market or private transaction""
FAQ
What insider transaction did INDV report for Anderson Woodrow D?
Indivior Pharmaceuticals, Inc. reported that Chief Accounting Officer Anderson Woodrow D purchased 1,500 shares of its Common Stock on August 27, 2026 in an open market or private transaction at $35.69 per share.
Was the INDV insider trade made under a Rule 10b5-1 trading plan?
The document-level Rule 10b5-1 checkbox is marked false, indicating the filing states the transaction was not affirmed as made pursuant to a Rule 10b5-1 trading plan.
What is the transaction code used in the INDV Form 4 for this trade?
The trade is reported with transaction code P, which the Form 4 description identifies as a “Purchase in open market or private transaction.” This corresponds to a buy of 1,500 shares of Indivior Common Stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
